COVID 19 in the critically ill
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
- Registration Number
- CTRI/2021/03/032312
- Lead Sponsor
- Fluid Research Grant Christian Medical College Vellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients admitted to the MICU who test positive for the COVID- 19 RT-PCR test over the duration of study and meet the inclusion criteria will be enrolled in the study
Exclusion Criteria
Anyone who does not give consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of ICU and hospital stay <br/ ><br>Mortality-ICU and hospital <br/ ><br>Nosocomial infection <br/ ><br>Need for ventilation and duration of ventilation <br/ ><br>Need and duration of muscle relaxants <br/ ><br>Tracheostomy <br/ ><br>Need and duration of renal replacement therapy <br/ ><br>Duration of renal replacement therapy <br/ ><br>Organ dysfunction through SOFA (Sequential Organ Failure Assessment) score <br/ ><br>Complications â?? Seizures, myocarditis, bleed, pulmonary embolism <br/ ><br>Timepoint: Baseline <br/ ><br>ICU discharge <br/ ><br>Hospital discharge <br/ ><br>1 month follow up
- Secondary Outcome Measures
Name Time Method osocomial infection <br/ ><br>Need for ventilation and duration of ventilation <br/ ><br>Need and duration of muscle relaxants <br/ ><br>Tracheostomy <br/ ><br>Need and duration of renal replacement therapy <br/ ><br>Duration of renal replacement therapy <br/ ><br>Organ dysfunction through SOFA (Sequential Organ Failure Assessment) score <br/ ><br>Complications â?? Seizures, myocarditis, bleed, pulmonary embolism <br/ ><br>Timepoint: Hospital length of stay